4BIO Ventures II fund solely focused on advanced therapies targeting $150 million final close 4BIO Capital (“4BIO” or “the Group”), an international venture capital firm focused solely on the advanced therapies sector, announces today that it has completed the first close of its second venture fund, 4BIO Ventures II. Over $50 million of capital has
Source Euronews Euronews space correspondent and European Space Agency (ESA) astronaut Luca Parmitano has been in space for a month now. His first mission was to “catch a Dragon” – a cargo vehicle which brings payloads for astronauts onboard the International Space Station (ISS). Once the dragon was “captured”, Luca and his team received new scientific equipment to start working on
Source Harvard University Twenty people die every day waiting for an organ transplant in the United States, and while more than 30,000 transplants are now performed annually, there are over 113,000 patients currently on organ waitlists. Artificially grown human organs are seen by many as the “holy grail” for resolving this organ shortage, and advances
Source NIH The normal human gut microbiome is a flourishing community of microorganisms, some of which can affect the human immune system. In a new paper published this week in Cell, researchers found that oral antibiotics, which can kill gut microorganisms, can alter the human immune response to seasonal influenza vaccination. The work was led by
“Untested, deceptive treatments” can endanger consumers, Internet giant says. Responding to ubiquitous online marketing by stem cell clinics selling unapproved treatments for everything from achy joints to Alzheimer’s, Google announced Friday it will no longer accept ads for “unproven or experimental medical techniques,” including most stem cell therapy, cellular therapy and gene therapy. The Internet
A team led by Roberta Diaz Brinton, PhD, director of the Center for Innovation in Brain Science, received the multi-million dollar grant from the National Institute on Aging. The five-year grant will fund a national multi-site Phase 2 clinical trial to determine the effectiveness of allopregnanalone, or allo, as a treatment for individuals with early-stage Alzheimer’s who
The FDA has released final guidance for its Humanitarian Device Exemption (HDE) program, incorporating changes wrought by the 21st Century Cures Act and the FDA Reauthorization Act, both passed in 2017. The agency said it developed the guidance to clarify current HDE program review practices — including the criteria it considers to determine if a
The University of Pittsburgh is teaming up with the International Space Station U.S. National Laboratory (ISSNL) to study how the low-gravity environment of space can improve treatments for kidney disease, traumatic brain injury and juvenile diabetes. Pitt’s McGowan Institute for Regenerative Medicine will collaborate with the ISSNL Industrial Biomedicine Program on research that will look
Gene therapies constitute a new concept of transformative therapies, administered once in a lifetime. The value assessment of these innovative therapies constitutes a challenge for health technology assessment (HTA) bodies. The HTA reports for all seven gene therapies that have to date been granted a market authorization in the European Union (EU) and/or the United
Taxing sugary snacks like cookies and cakes may have a substantially larger impact in fighting obesity than levies on sweetened drinks, suggests a new study. Using economic modeling, UK researchers found that increasing sugary snack prices by 20% had an effect on annual calorie intake, body mass index (BMI), and obesity prevalence much greater than that of a
